Primary Record
Rubitecan
- In stock
- 9,712 g
- Purity
- 99.0 %
- CAS
- 91421-42-0
Compound Identifiers & Properties
- CAS
- 91421-42-0
- PubChem CID
- 472335
- SMILES
- CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O
- Canonical SMILES
- CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1
Names & Synonyms
- Rubitecan
- 9-Nitrocamptothecin
- Orathecin
- Camptogen
- 91421-42-0
- rubitecanum
- Nitrocamptothecin
- 9-nitro-20(S)-camptothecin
- rubetican
- 9-NC
- Inhaled Orathecin
- Rubitecan [USAN]
- 9-Nitro-CPT
- Rubitecan (inhaled)
- RFS 2000
- 9-nitro camptothecin
- 9-Amino-camptothecin
- RFS-2000
- Rubitecan [USAN:INN]
- AC1LAOVR
- RUBITECAN [INN]
- 9-nitro-(20S)-camptothecin
- RUBITECAN [MI]
- Rubitecan (USAN/INN)
- L9NC
- RefChem:883953
- RFS2000
- Camptothecin Impurity 13
- H19C446XXB
- UNII-H19C446XXB
- 9-nitro-20-(S)-camptothecin
- Ruboxistaurin Hydrochloride
- DTXSID7046752
- MFCD06656294
- #NAME?
- CHEBI:90225
- D0I5XO
- D0Y1FO
- RUBITECAN [MART.]
- RUBITECAN [WHO-DD]
- SCHEMBL8640
- 9-nitrocamptothecin, (S)-
- C20H15N3O6
- DTXCID5026752
- RFS 2000;9-Nitrocamptothecin
- 9-Nitrocamptothecin (9-NC)
- ethyl-hydroxy-nitro-[?]dione
- CHEMBL77305
- 9-nitro-20(s)-camptothecine
- Rubitecan (inhaled), SuperGen
- AC1Q21R5
- orb1301430
- 86639-62-5
- SCHEMBL29379605
- SCHEMBL29383355
- camptothecin, 9-nitro-20(s)-
- CTK8B3048
- 9-nitrocamptothecin, (S)-isomer
- WLZ3809
- VHXNKPBCCMUMSW-FQEVSTJZSA-N
- BCP06207
- EBD39671
- EX-A4326
- Rubitecan, 98% - 10MG 10mg
- ZINC3827362
- 9-nitrocamptothecin (rubitecan)
- Tox21_112597
- 3600AC
- ABP001092
- ANW-41681
- AR-1H5905
- BDBM50248354
- CID472335
- CN-061
- NCGC00167969-01
- NSC603070
- s2288
- AKOS015895332
- AKOS025149224
- C20-H15-N3-O6
- (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- ACN-056771
- CID:472335
- DB06159
- EBC-615615
- FR27767
- RL05757
- ST-2617
- KS-000017A1
- NCGC00167969-02
- NCGC00167969-03
- AC-13389
- AC-25083
- AC-33157
- AJ-45745
- AS-14856
- BC206171
- BP-41442
- HY-13744
- M884
- SC-54565
- SID:53790631
- SY078302
- AB3000004
- CAS-91421-42-0
- J448.357J
- LY 333531
- TR-038378
- CS-0007769
- FT-0630977
- N0822
- ST24036187
- D04031
- 421R420
- A847954
- C079905
- Q510113
- (S)-4-Ethyl-4-hydroxy-9-nitro-1H-pyrano[3',4'
- Aerosolized liposomal 9 nitro-20 (S) camptothecin
- I06-2270
- BRD-K79821389-001-01-9
- BRD-K79821389-001-03-5
- (s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
- 9NC
- B2692-079493
- (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
- (4s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
- 104195-61-1
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-10-nitro-, (4S)-
- 4-Ethyl-4-hydroxy-9-nitro-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
- 9-NC, 9-Nitro-camptothecin, Partaject Orathecin, Partaject rubitecan, RFS 2000
- (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo(11.8.0.0^(2,11).0^(4,9).0^(15,20))henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (4S)-10-Nitro-4-ethyl-4-hydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Nitro-20(S)-camptothecin; 9-Nitrocamptothecin; Orathecin
- (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizinol[1,2-b]quinoline-3,14(4H,-12H)-dione
- (4S)-4alpha-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4alpha-Ethyl-4-hydroxy-10-nitro-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-4beta-Hydroxy-4-ethyl-10-nitro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (9S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione Hydrochloride
- (S)-4-ethyl-4-hydroxy-10-nitro-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
- (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3\',4\':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 169939-93-9
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-
- 4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 4|A-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
- 4alpha-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 4alpha-Ethyl-4beta-hydroxy-10-nitro-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- 51-45-6
- 87988-63-4
- Rubitecan; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-10-nitro-, (4S)-